Natriumklorid Fresenius Kabi (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumklorid Fresenius Kabi, is an electrolyte presented as an injection solution for intravenous use. It restores extracellular fluid volume and sodium chloride balance, and is employed in fluid replacement, electrolyte balance, and blood pressure support for patients requiring intravenous therapy.

GNH USA supplies Natriumklorid Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Natriumklorid is used in clinical situations that require intravenous electrolyte and volume management.

- Fluid replacement: restores intravascular volume in dehydration or blood loss. - Electrolyte balance: corrects sodium chloride deficits in hypovolemia. - Blood pressure support: assists in maintaining hemodynamic stability during acute care.

Adverse reactions may occur with intravenous sodium chloride administration.

Common Side Effects: - Injection site pain: discomfort at the infusion site. - Phlebitis: inflammation of the vein used for infusion. - Mild hypernatremia: transient elevation of serum sodium. - Rash or mild hypersensitivity: skin redness or itching.

Serious or Rare Side Effects: - Severe hypernatremia: marked increase in serum sodium leading to neurological symptoms. - Fluid overload: pulmonary edema or heart failure exacerbation. - Anaphylactic reaction: rapid onset of airway compromise and hypotension. - Cardiac arrhythmia: caused by abrupt electrolyte shifts.

When using Natriumklorid, clinicians should consider specific safety measures.

- Renal impairment: monitor fluid status and serum electrolytes closely. - Cardiac failure: avoid excessive volume administration. - Electrolyte disorders: verify baseline sodium levels before infusion. - Pediatric patients: adjust volume carefully according to weight. - Pregnancy: use only if clearly needed after risk assessment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intravenous sodium chloride may interact with other medications affecting fluid and electrolyte balance.

Major Interactions (Avoid): - Loop diuretics: can cause excessive sodium loss leading to imbalance. - Corticosteroids: may increase sodium retention and fluid overload risk. - ACE inhibitors combined with potassium supplements: heightened risk of electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Hypertonic solutions: risk of severe hypernatremia if co‑administered. - Blood products: may alter overall electrolyte composition. - Other IV electrolytes: adjust dosing to prevent cumulative sodium excess.